L
Lantern
Formerly known as Employer Direct Healthcare | Specialty care platform for employer health plans.
About Lantern
Lantern operates as a specialty care platform designed to connect members of self-funded employer health plans with high-quality, cost-effective medical care for complex needs. The company, headquartered in Dallas, Texas, targets the highest-cost areas of healthcare spend for employers, which include surgery, cancer care, and infusion therapies. Lantern's business model is centered on providing a supplemental health benefit to large employers, public sector entities, and labor unions. It curates a proprietary "Network of Excellence" by directly contracting with top-performing specialists and facilities, including ambulatory surgery centers and hospitals, across the United States. This model aims to deliver significant cost savings to employers—reportedly over 55% lower rates than average health plans—while improving clinical outcomes for patients. The company was founded in 2010, and was previously known as Employer Direct Healthcare and operated with SurgeryPlus as its core product. In September 2024, the company rebranded to Lantern to reflect its expansion beyond surgery into a multi-faceted specialty care platform. John Zutter, who has a background in investment banking and private equity with J.P. Morgan and Dundon Capital Partners, joined as CEO in 2016. Under his leadership, Lantern grew from approximately 100,000 members to over 6 million, serving more than 1,000 employers. The company's growth was supported by several funding rounds, including a $30 million investment in March 2026 led by Morgan Health, a JPMorgan Chase business unit, and Echo Health Ventures. Lantern's platform functions as an evolution of the traditional Centers of Excellence (COE) model by emphasizing local, accessible care to drive higher utilization. The company reports that providing local access can increase utilization by five to eight times compared to models requiring travel. For members, Lantern provides a dedicated care team of care advocates and nurses who offer personalized support throughout their entire treatment journey, from diagnosis and scheduling to post-treatment follow-up. This service helps members navigate the complex healthcare system, access second opinions, and get scheduled for care faster than the national average. The platform's key services cover planned surgeries, comprehensive cancer care, and both in-home and ambulatory infusion therapies.
Source: Dealroom company dataKnowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| GROWTH EQUITY VC✓Equity / VC | Mar 2026 | $30M | — | Echo Health Ventures · Morgan Health | ↗ |
| SECONDARY✓Other financing | Dec 2023 | $92M | $1B | Insight Partners | ↗ |
Growth signals
Latest recorded traffic for Lantern is 31K monthly website visits, up 5640.7% over the last three months. Lantern's team grew 18.6% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A1 investor entered at this stage
TEXO Ventures
Series B and later5 investors entered at this stage
Dundon capital partners
Serent Capital
Insight Partners
Morgan Health
Echo Health Ventures
Other known investors4 additional known investors
Risk Strategies
Central Texas Angel Network
Randall Crowder
Wild Basin Investments
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Lantern on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Lantern’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







